1 |
Karagoz K, Stokes M, Ortiz-Estévez M, Towfic F, Flynt E, Gooding S, Pierceall W, Thakurta A. Multiple Myeloma Patient Tumors With High Levels of Cereblon Exon-10 Deletion Splice Variant Upregulate Clinically Targetable Pro-Inflammatory Cytokine Pathways. Front Genet 2022;13:831779. [PMID: 35222546 DOI: 10.3389/fgene.2022.831779] [Reference Citation Analysis]
|
2 |
Taiana E, Gallo Cantafio ME, Favasuli VK, Bandini C, Viglietto G, Piva R, Neri A, Amodio N. Genomic Instability in Multiple Myeloma: A "Non-Coding RNA" Perspective. Cancers (Basel) 2021;13:2127. [PMID: 33924959 DOI: 10.3390/cancers13092127] [Reference Citation Analysis]
|
3 |
Shyamsunder P, Sridharan SP, Madan V, Dakle P, Zeya C, Kanojia D, Chng WJ, Ong ST, Koeffler HP. THZ531 Induces a State of BRCAness in Multiple Myeloma Cells: Synthetic Lethality with Combination Treatment of THZ 531 with DNA Repair Inhibitors. Int J Mol Sci 2022;23:1207. [PMID: 35163134 DOI: 10.3390/ijms23031207] [Reference Citation Analysis]
|
4 |
Liu Y, Hua Q, Li M, Li X, Chen W, Zeng H, Diao Q, Shi C, Ling Y, Jiang Y. Circular RNA circNIPBL promotes NNK-induced DNA damage in bronchial epithelial cells via the base excision repair pathway. Arch Toxicol 2022. [PMID: 35435490 DOI: 10.1007/s00204-022-03297-z] [Reference Citation Analysis]
|